Does hepatitis B minor yang need to be treated?
Whether hepatitis B minor yang needs treatment is a relatively complex question because the answer depends on multiple factors. Hepatitis B small triple positive refers to the situation where the hepatitis B surface antigen, hepatitis B e antibody, and core antibody are positive during a hepatitis B virus two-and-a-half serological test.
If the patient's liver function is normal and there are no other uncomfortable symptoms, in most cases, no special treatment is needed for hepatitis B minor yang. This is because many patients with small triple positive hepatitis B have low or even undetectable levels of viral replication, and their liver function remains normal. At this time, what the patient needs is regular examination and observation to ensure that the condition does not progress further.
In some cases, patients with small triple positive hepatitis B need to receive treatment. For example, if a patient's liver is uncomfortable, or if liver function tests reveal abnormalities, such as persistent abnormalities in indicators such as alanine aminotransferase, this may mean that the liver has been damaged. In addition, if the patient has other diseases, such as cirrhosis, glomerulonephritis, vasculitis, etc., or is older than 30 years old and is positive for hepatitis B virus DNA, these conditions require timely treatment to prevent irreversible damage to the liver.
For patients who need treatment, treatment methods for hepatitis B minor three positives mainly include antiviral treatment, immunomodulatory treatment, liver-protecting treatment, etc. Antiviral treatment is the key. Antiviral drugs such as entecavir tablets and tenofovir disoproxil fumarate tablets can be used to inhibit viral replication and reduce liver inflammation. At the same time, patients also need to pay attention to lifestyle adjustments, such as maintaining adequate sleep, exercising appropriately, avoiding overexertion, and maintaining a good mentality.
(Click to view an introduction to drugs for the treatment of hepatitis B.)
References:
https://ybsite.org/en/symptom/h-4900.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)